扩展与简单胆囊切除在第一阶段胆囊癌:基于SEER的竞争风险分析与外部验证
Ziqiang Wang1, Yangyang Xie2, Xiaowen Li3
1The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311000, China.
World journal of surgical oncology
|November 11, 2025
概括
对于早期的胆囊癌 (GBC),扩展胆囊切除术 (EC) 显示出比简单胆囊切除术 (SC) 更好的生存率. 诺米图可以预测结果,帮助T1b GBC患者的治疗决策.
科学领域:
- 手术瘤学手术瘤学
- 胃肠道瘤学 胃肠道瘤学
- 癌症流行病学 癌症流行病学
背景情况:
- 对于早期胆囊癌 (GBC) 的最佳手术方法仍在争论中.
- 简单胆囊切除术 (SC) 与扩展胆囊切除术 (EC) 的长期结果需要澄清.
研究的目的:
- 在I期GBC中比较SC和EC的长期存活率.
- 评估GBC患者预测结果的预测模型.
主要方法:
- 利用了902名I期GBC患者的SEER数据库 (2010-2015年).
- 应用Kaplan-Meier分析,倾向得分匹配 (PSM) 和竞争风险模型.
- 开发并验证了竞争性风险名ograms用于结果预测.
主要成果:
- 在PSM后,EC组的癌症特异性死亡率 (CSD) 显著降低 (5年:15.3%对比28.9%,P=0.002).
- 在T1b,高度和腺癌GBC中,SC与较高的CSD相关.
- 诺米图准确地预测了通过强烈的歧视和校准来预测CSD的概率.
结论:
- 推EC用于T1b GBC;SC可能足以用于T1a GBC.
- 开发出来的诺姆图提供了可靠的预测,以指导临床决策.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
478
05:36Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
Published on: May 2, 2025
597
相关概念视频
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
